The global eubiotics market was valued at USD 6.3 billion in 2025 and is projected to grow from USD 6.8 billion in 2026 to USD 12.6 billion by 2033, registering a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033. Europe dominated the market, accounting for 43.0% of global revenue in 2025. Market growth is driven by favorable regulatory developments restricting antibiotic use in...